KalVista Pharmaceuticals to Present at 13th Annual Jefferies Healthcare Conference
businesswire.com
news
2022-06-01 00:00:00

June 01, 2022 06:45 AM Eastern Daylight Time CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced it will be presenting at the 13th Annual Jefferies Global Healthcare Conference on Wednesday, June 8, 2022 at 11:30 a.m. ET.

A live webcast of the presentation will be available on the Company's website at www.
